chr1-77044405-A-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_030965.3(ST6GALNAC5):c.463A>T(p.Asn155Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000979 in 1,613,172 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000053 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00010 ( 0 hom. )
Consequence
ST6GALNAC5
NM_030965.3 missense
NM_030965.3 missense
Scores
2
9
8
Clinical Significance
Conservation
PhyloP100: 7.25
Genes affected
ST6GALNAC5 (HGNC:19342): (ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5) The protein encoded by this gene is a Golgi type II transmembrane glycosyltransferase. The encoded protein catalyzes the transfer of sialic acid to cell surface proteins to modulate cell-cell interactions. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ST6GALNAC5 | NM_030965.3 | c.463A>T | p.Asn155Tyr | missense_variant | 3/5 | ENST00000477717.6 | NP_112227.1 | |
ST6GALNAC5 | NM_001320273.2 | c.262-5853A>T | intron_variant | NP_001307202.1 | ||||
ST6GALNAC5 | NM_001320274.2 | c.262-18570A>T | intron_variant | NP_001307203.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ST6GALNAC5 | ENST00000477717.6 | c.463A>T | p.Asn155Tyr | missense_variant | 3/5 | 1 | NM_030965.3 | ENSP00000417583 | P1 | |
ST6GALNAC5 | ENST00000488940.1 | n.266A>T | non_coding_transcript_exon_variant | 2/3 | 5 | |||||
ST6GALNAC5 | ENST00000318803.6 | c.463A>T | p.Asn155Tyr | missense_variant, NMD_transcript_variant | 3/5 | 5 | ENSP00000436263 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152082Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
8
AN:
152082
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000440 AC: 11AN: 250268Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135424
GnomAD3 exomes
AF:
AC:
11
AN:
250268
Hom.:
AF XY:
AC XY:
4
AN XY:
135424
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000103 AC: 150AN: 1461090Hom.: 0 Cov.: 31 AF XY: 0.0000949 AC XY: 69AN XY: 726852
GnomAD4 exome
AF:
AC:
150
AN:
1461090
Hom.:
Cov.:
31
AF XY:
AC XY:
69
AN XY:
726852
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152082Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74270
GnomAD4 genome
AF:
AC:
8
AN:
152082
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
74270
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
3
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 17, 2024 | The c.463A>T (p.N155Y) alteration is located in exon 3 (coding exon 3) of the ST6GALNAC5 gene. This alteration results from a A to T substitution at nucleotide position 463, causing the asparagine (N) at amino acid position 155 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Benign
T
MetaRNN
Uncertain
D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Benign
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
P
Vest4
MutPred
Gain of helix (P = 0.0425);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at